Pharmacokinetic and pharmacodynamic interactions of bretazenil and diazepam with alcohol

British Journal of Clinical Pharmacology

Volumn 41, Issue 6, 1996, Pages 565-573

  Van Steveninck, A L ^a   Gieschke, R ^b   Schoemaker, R C ^a   Roncari, G ^b   Tuk, B ^a   Pieters, M S M ^a   Breimer, D D ^c   Cohen, A F ^a,d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c Ctr for Bio Pharmaceutical Sciences   (Netherlands)

^d CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

Author keywords

alcohol interaction; bretazenil; diazepam; performance; pharmacokinetics

Indexed keywords

ALCOHOL; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; BRETAZENIL; DIAZEPAM; GLUCOSE; PLACEBO;

ADULT; ANXIETY; ARTICLE; BODY EQUILIBRIUM; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ALCOHOL INTERACTION; DRUG HALF LIFE; DRUG MIXTURE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; NAUSEA; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PANIC; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; RANDOMIZED CONTROLLED TRIAL; SEDATION; SMOOTH PURSUIT EYE MOVEMENT; SUBLINGUAL DRUG ADMINISTRATION; TRANQUILIZING ACTIVITY; VOMITING;

EID: 0029990667     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1996.38514.x     Document Type: Article

References (21)

1. Haefely W, Martin JR, Schoch P. Novel anxiolytics that act as partial agonists at benzodiazepine receptors. Trends Pharmacol Sci 1990; 11: 452-456.
2. Potokar J, Nutt DJ. Anxiolytic potential of benzodiazepine receptor partial agonist. CNS Drugs 1994; 1: 305-315
3. Potier MC, Prado de Carvalho L, Venault P, Chapouthier G, Rossier J. Demonstration of the partial agonist profiles of Ro 16-6028 and Ro 17-1812 in mice in vivo. Eur J Pharmacol 1988; 156: 169-172.
4. Marley RJ, Gallager DW. Chronic diazepam treatment produces regionally specific changes in GABA-stimulated chloride influx. Eur J Pharmacol 1989; 159: 217-223.
5. Saletu B, Grünberger J, Linzmayer L. On the central effects of a new partial benzodiazepine agonist Ro 16-6028 in man: pharmaco-EEG and psychometric studies. Int J clin Pharmacol Ther Toxicol 1989; 27: 51-65.
6. Katschnig H, Merz WA, Alf C. Attack-controlled discontinuous administration of RO 16-6028 as a new strategy in the treatment of panic disorder: Results of a placebo controlled double blind study. Psychopharmacology 1988; 96 (suppl): 253.
7. Cowley DS. Alcohol abuse, substance abuse, and panic disorder. Am J Med 1992; 92 (suppl 1A): 41S-48S.
8. Van Steveninck AL, Gieschke R, Schoemaker HC et al. Pharmacodynamic interactions of diazepam and intravenous alcohol at pseudo steady state. Psychopharmacology 1993; 110: 471-478.
9. Hartmann D, Flückiger A, Ziegler WH, Timm U, Zell M. Experimental model for the investigation of kinetic and/or dynamic interactions between drugs and ethanol in humans. J Pharmacol Sci 1988; 77: 299-301.
10. Bond A, Lader M. The use of analogue scales in rating subjective feelings. Br J med Psychol 1974; 47: 211-218.
11. Timm U, Fischer G, Zell M, Zumbrunnen R. Determination of the partial benzodiazepine receptor agonist Ro 16-6028 in plasma by capillary gas chromatography with nitrogen-selective detection after conversion into the ethyl ester derivative. J Chromatogr 1989; 494: 119-134.
12. Cotler S, Puglisi CV, Gustafson JH. Determination of diazepam and its major metabolites in man and in the cat by high-performance liquid-chromatography. J Chromatogr 1981; 222: 95-106.
13. Bittencourt PRM, Wade P, Smith AT, Richens A. Benzodiazepines impair smooth pursuit eye movements. Br J Clin Pharmacol 1983; 15, 259-262.
14. Van Steveninck AL, Kroon JM, Schoemaker HC, Pieters MSM, Breimer DD, Cohen AF. A study comparing the sensitivities of adaptive tracking, eye movement analysis and visual analogue lines to the effects of incremental doses of temazepam in healthy volunteers. Clin Pharmacol Ther 1991; 50: 172-180.
15. Haefely W. Partial agonists of the benzodiazepine receptor: from animal data to results in patients. In Chloride channels and their modulation by neurotransmitters and drugs, eds Biggio G, Costa E, New York: Raven Press, 1988: 275-292.
16. Kemp JA, Wafford K, Horne AL, Marshall GR, Whiting P. Functional determination of benzodiazepine receptor ligand efficacy. J Psychopharmacol 1992; BAP/EBPS Abstracts, A33: 132.
17. Sanger DJ, Perrault G, Morel E, Joly D, Zivkovic B. Animal models of anxiety and the development of novel anxiolytic drugs. Prog Neuro Psychopharmacol 1991; 15: 205-212.
18. Roy Byrne PP, Cowley DS, Greenblatt DJ, Shader RI, Hommer D. Reduced benzodiazepine sensitivity in panic disorder. Arch Gen Psychiat 1990; 47: 534-538.
19. Nutt DJ, Glue P, Lawson C, Wilson S. Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder. Arch Gen Psychiat 1990; 47: 917-925.
20. Sellers EM, Busto U, Kaplan HL. Clinical abuse liability of partial and full agonist benzodiazepines: a comparison of bretazenil, diazepam and alprazolam. In Biological Psychiatry (Proc. of the 5th World Congress of Biol.Psych.), eds Racagni G, et al., Amsterdam: Elsevier Science Publishers, 1991: 709-712.
21. Rall TW. Hypnotics and sedatives. In The pharmacological basis of therapeutics, eds Goodman Gilman A, Goodman LS, Rall TW, Murad F, New York: Macmillan, 1990: 345-382.